FR2885527B1 - Composition pharmaceutique comprenant un onguent oleagineux et de la vitamine d ou ses derives a l'etat solubilise - Google Patents

Composition pharmaceutique comprenant un onguent oleagineux et de la vitamine d ou ses derives a l'etat solubilise

Info

Publication number
FR2885527B1
FR2885527B1 FR0504889A FR0504889A FR2885527B1 FR 2885527 B1 FR2885527 B1 FR 2885527B1 FR 0504889 A FR0504889 A FR 0504889A FR 0504889 A FR0504889 A FR 0504889A FR 2885527 B1 FR2885527 B1 FR 2885527B1
Authority
FR
France
Prior art keywords
vitamin
derivatives
pharmaceutical composition
oleaginous ointment
solubilized
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0504889A
Other languages
English (en)
Other versions
FR2885527A1 (fr
Inventor
Nathalie Barthez
Sandrine Orsoni
Laurent Fredon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma Research and Development SNC
Original Assignee
Galderma Research and Development SNC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0504889A priority Critical patent/FR2885527B1/fr
Application filed by Galderma Research and Development SNC filed Critical Galderma Research and Development SNC
Priority to CA002608383A priority patent/CA2608383A1/fr
Priority to CNA2006800167253A priority patent/CN101175497A/zh
Priority to JP2008511744A priority patent/JP5079689B2/ja
Priority to PCT/FR2006/000971 priority patent/WO2006123031A2/fr
Priority to KR1020077026645A priority patent/KR20080007608A/ko
Priority to AU2006248878A priority patent/AU2006248878A1/en
Priority to BRPI0612911-0A priority patent/BRPI0612911A2/pt
Priority to EP06764575A priority patent/EP1885374A2/fr
Publication of FR2885527A1 publication Critical patent/FR2885527A1/fr
Application granted granted Critical
Publication of FR2885527B1 publication Critical patent/FR2885527B1/fr
Priority to US11/984,392 priority patent/US20100286285A1/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
    • B82B3/00—Manufacture or treatment of nanostructures by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/592—9,10-Secoergostane derivatives, e.g. ergocalciferol, i.e. vitamin D2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/08—Antiseborrheics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01L—SEMICONDUCTOR DEVICES NOT COVERED BY CLASS H10
    • H01L21/00—Processes or apparatus adapted for the manufacture or treatment of semiconductor or solid state devices or of parts thereof
    • H01L21/02—Manufacture or treatment of semiconductor devices or of parts thereof
    • H01L21/04—Manufacture or treatment of semiconductor devices or of parts thereof the devices having potential barriers, e.g. a PN junction, depletion layer or carrier concentration layer
    • H01L21/18—Manufacture or treatment of semiconductor devices or of parts thereof the devices having potential barriers, e.g. a PN junction, depletion layer or carrier concentration layer the devices having semiconductor bodies comprising elements of Group IV of the Periodic Table or AIIIBV compounds with or without impurities, e.g. doping materials
    • H01L21/20—Deposition of semiconductor materials on a substrate, e.g. epitaxial growth solid phase epitaxy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Nanotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Manufacturing & Machinery (AREA)
  • Transplantation (AREA)
  • Physics & Mathematics (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • General Physics & Mathematics (AREA)
  • Computer Hardware Design (AREA)
  • Microelectronics & Electronic Packaging (AREA)
  • Power Engineering (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR0504889A 2005-05-16 2005-05-16 Composition pharmaceutique comprenant un onguent oleagineux et de la vitamine d ou ses derives a l'etat solubilise Expired - Fee Related FR2885527B1 (fr)

Priority Applications (10)

Application Number Priority Date Filing Date Title
FR0504889A FR2885527B1 (fr) 2005-05-16 2005-05-16 Composition pharmaceutique comprenant un onguent oleagineux et de la vitamine d ou ses derives a l'etat solubilise
EP06764575A EP1885374A2 (fr) 2005-05-16 2006-04-28 Composition pharmaceutique comprenant un onguent oleagineux et de la vitamine d ou ses derives a l'etat solubilise
JP2008511744A JP5079689B2 (ja) 2005-05-16 2006-04-28 油性軟膏と可溶化された形態のビタミンｄまたはその誘導体とを含む薬剤組成物
PCT/FR2006/000971 WO2006123031A2 (fr) 2005-05-16 2006-04-28 Composition pharmaceutique comprenant un onguent oleagineux et de la vitamine d ou l’un de ses derives a l'etat solubilise
KR1020077026645A KR20080007608A (ko) 2005-05-16 2006-04-28 유지성 연고 및 비타민 ｄ 또는 이의 유도체를 가용화형태로 포함하는 약학 조성물
AU2006248878A AU2006248878A1 (en) 2005-05-16 2006-04-28 Pharmaceutical composition comprising an oleaginous ointment and vitamin D or the derivatives thereof in solubilised form
CA002608383A CA2608383A1 (fr) 2005-05-16 2006-04-28 Composition pharmaceutique comprenant un onguent oleagineux et de la vitamine d ou l'un de ses derives a l'etat solubilise
CNA2006800167253A CN101175497A (zh) 2005-05-16 2006-04-28 含有溶解状态的油状的软膏和维生素d或其衍生物的药用组合物
BRPI0612911-0A BRPI0612911A2 (pt) 2005-05-16 2006-04-28 composição farmacêutica anidra, uso da vitamina d e uso da composição
US11/984,392 US20100286285A1 (en) 2005-05-16 2007-11-16 Pharmaceutical composition comprising oleaginous ointments and vitamin D or its derivatives in the solubilized state

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0504889A FR2885527B1 (fr) 2005-05-16 2005-05-16 Composition pharmaceutique comprenant un onguent oleagineux et de la vitamine d ou ses derives a l'etat solubilise

Publications (2)

Publication Number Publication Date
FR2885527A1 FR2885527A1 (fr) 2006-11-17
FR2885527B1 true FR2885527B1 (fr) 2007-06-29

Family

ID=35462160

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0504889A Expired - Fee Related FR2885527B1 (fr) 2005-05-16 2005-05-16 Composition pharmaceutique comprenant un onguent oleagineux et de la vitamine d ou ses derives a l'etat solubilise

Country Status (10)

Country Link
US (1) US20100286285A1 (fr)
EP (1) EP1885374A2 (fr)
JP (1) JP5079689B2 (fr)
KR (1) KR20080007608A (fr)
CN (1) CN101175497A (fr)
AU (1) AU2006248878A1 (fr)
BR (1) BRPI0612911A2 (fr)
CA (1) CA2608383A1 (fr)
FR (1) FR2885527B1 (fr)
WO (1) WO2006123031A2 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006100154A1 (fr) 2005-03-24 2006-09-28 Nolabs Ab Traitement cosmetique au monoxyde d'azote, dispositif pour la mise en oeuvre de ce traitement, et procede de fabrication correspondant
JP2008222662A (ja) * 2007-03-14 2008-09-25 Betafarma Spa アトピー性皮膚炎を処置する衛生用および化粧用の組成物
FR2931662B1 (fr) * 2008-05-30 2010-07-30 Galderma Res & Dev Nouvelles compositions depigmentantes sous forme d'une composition anhydre sans vaseline et sans elastomere comprenant un derive phenolique solubilise.
ES2958410T3 (es) 2009-08-21 2024-02-08 Novan Inc Geles tópicos
WO2013006608A1 (fr) 2011-07-05 2013-01-10 Novan, Inc. Compositions topiques
EP2833721B1 (fr) * 2012-03-14 2021-02-17 Novan Inc. Compositions pharmaceutiques libérant de l'oxyde nitrique
US9855211B2 (en) 2013-02-28 2018-01-02 Novan, Inc. Topical compositions and methods of using the same
WO2015021382A2 (fr) 2013-08-08 2015-02-12 Novan, Inc. Compositions topiques et procédés d'utilisation de celles-ci
US10206947B2 (en) 2013-08-08 2019-02-19 Novan, Inc. Topical compositions and methods of using the same
EP3253370A4 (fr) * 2015-02-05 2018-08-01 Marc Selner Suspension de nano-vésicules ioniques et biocide préparé à partir d'une telle suspension
EP3423100A4 (fr) 2016-03-02 2019-10-16 Novan, Inc. Compositions destinées à traiter l'inflammation et méthodes de traitement associées
JP6899845B2 (ja) 2016-04-13 2021-07-07 ノヴァン，インコーポレイテッド 感染症を治療するための組成物、システム、キットおよび方法
CN106902075A (zh) * 2017-02-23 2017-06-30 任君刚 一种基于无水技术的水敏感粘附性软膏及其制备方法
CN112165935A (zh) 2018-03-01 2021-01-01 诺万公司 一氧化氮释放性栓剂及其使用方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4335120A (en) * 1979-03-21 1982-06-15 Hoffmann-La Roche Inc. Administration of biologically active vitamin D3 and vitamin D2 materials
JPS6226223A (ja) * 1985-07-25 1987-02-04 Teijin Ltd 乾癬治療剤
CA1272953A (fr) * 1984-10-08 1990-08-21 Yuji Makino Compose pharmaceutique pour usage externe contenant de la vitasmine d.sub.3 de type acitf
JP3506505B2 (ja) * 1994-09-27 2004-03-15 帝人株式会社 白斑治療剤
JPH08119865A (ja) * 1994-10-26 1996-05-14 Teijin Ltd 神経線維腫症治療剤
FR2761889B1 (fr) * 1997-04-11 1999-12-31 Oreal Patch pharmaceutique, cosmetique ou dermo-pharmaceutique pour la delivrance de plusieurs composes actifs de nature differente
CN1367699A (zh) * 1999-07-09 2002-09-04 Bsp药物有限公司 含有牛油果树提取物的组合物及其作为药物或食品增补剂的用途
FR2833258B1 (fr) * 2001-12-10 2004-08-27 Galderma Res & Dev Analogues de la vitamine d
US6924400B2 (en) * 2001-12-10 2005-08-02 Galderma Research & Development, Snc Triaromatic vitamin D analogues
US7060260B2 (en) * 2003-02-20 2006-06-13 E.I. Du Pont De Nemours And Company Water-soluble silk proteins in compositions for skin care, hair care or hair coloring
FR2871694B1 (fr) * 2004-06-17 2008-07-04 Galderma Sa Composition pharmaceutique comprenant un onguent oleagineux et deux principes actifs solubilises

Also Published As

Publication number Publication date
CN101175497A (zh) 2008-05-07
AU2006248878A1 (en) 2006-11-23
BRPI0612911A2 (pt) 2010-12-07
WO2006123031A3 (fr) 2006-12-28
FR2885527A1 (fr) 2006-11-17
JP5079689B2 (ja) 2012-11-21
CA2608383A1 (fr) 2006-11-23
US20100286285A1 (en) 2010-11-11
KR20080007608A (ko) 2008-01-22
WO2006123031A2 (fr) 2006-11-23
EP1885374A2 (fr) 2008-02-13
JP2008540619A (ja) 2008-11-20

Similar Documents

Publication Publication Date Title
FR2885527B1 (fr) Composition pharmaceutique comprenant un onguent oleagineux et de la vitamine d ou ses derives a l'etat solubilise
FR2840903B1 (fr) Derive de glucose et de vitamine f, compositions le comprenant et utilisations pour ameliorer l'etat des poils et des cheveux
FR2909284B1 (fr) Nouvelles compositions sous forme d'onguent sans vaseline comprenant un derive de vitamine d et eventuellement un anti-inflammatoire steroidien
MA29090B1 (fr) Composes inhibiteurs de la phosphorylase du glycogene et compositions pharmaceutiques les comprenant
FR13C0062I2 (fr) Compositions pharmaceutiques comprenant du dextromethorphan et de la quinidine pour traiter des troubles neurologiques
RS52651B (en) PHARMACEUTICAL COMPOSITION CONTAINING GESTAGENS AND / OR ESTROGENS AND 5-METHYL- (6S) -TETRAHYDROPHOLATE
FR2774909B1 (fr) Formulation pharmaceutique, solution de perfusion et composition lyophilisee comprenant une epothilone.
NO20053076D0 (no) Farmasoytisk formulering med en uloselig aktiv forbindelse.
IL207028A0 (en) Pharmaceutical nati-tnf-alpha antibody formulation
FR2779438B1 (fr) Gel stable, son procede de preparation, et compositions pharmaceutiques le comprenant
ITTO20010005A1 (it) Formulazione farmaceutica.
EE200200357A (et) Ravimaine suurenenud kontsentratsioone andvad farmatseutilised kompositsioonid
ATE271392T1 (de) Lipoproteinkomplexe und zusammensetzungen, die diese enthalten
FR2792529B1 (fr) Nouvelles compositions pharmaceutiques comprenant des derives de 2-isoxazole-8-aminotetralines
IL181216A0 (en) 3, 5-seco-4-norcholestane derivatives and pharmaceutical compositions containing the same
ITRM20030363A0 (it) Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico diesse.
SI1377316T1 (sl) Farmacevtska spojina na osnovi azalidov za lokalno uporabo na področju oftalmologije
FR2797444B1 (fr) Compositions pharmaceutiques comprenant des 4-quinolones
MA26604A1 (fr) Compositions pharmaceutiques.
FR2884419B1 (fr) Composition de type solution filmogene comprenant de la vitamine d ou un de ses derives et un corticosteroide, et son utilisation en dermatologie
AU2003245774A1 (en) Pharmaceutical dosage form bearing pregnancy-friendly indicia
FR2864235B1 (fr) Systeme de test et procede pour mesurer l'etancheite de gants, notamment dans des installations pharmaceutiques
FR2916968B1 (fr) Composition cosmetique, dermatologique, alimentaire, nutritionnelle ou pharmaceutique a base de phosphatidylcholine, de cafeine et d'un extrait d'algue.
ITMI20020872A1 (it) Derivati dell'iperforina loro uso e formulazioni che li contengono
BRPI0410638A (pt) derivados de azitromicina

Legal Events

Date Code Title Description
CA Change of address
ST Notification of lapse

Effective date: 20140131